Transplantation最新文献

筛选
英文 中文
Outcomes of Donation After Circulatory Death Lung Transplantation in the United States Based on Procurement Strategies: A United Network for Organ Sharing Analysis. 基于采购策略的美国循环死亡肺移植后捐赠的结果:一个器官共享分析的联合网络。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-06-17 DOI: 10.1097/TP.0000000000005803
Ervin Y Cui, Doug A Gouchoe, Divyaam Satija, Martin G Walsh, Aaron Gou, Ammu V Alvarez, Matthew C Henn, Asvin M Ganapathi, Kukbin Choi, Bryan A Whitson
{"title":"Outcomes of Donation After Circulatory Death Lung Transplantation in the United States Based on Procurement Strategies: A United Network for Organ Sharing Analysis.","authors":"Ervin Y Cui, Doug A Gouchoe, Divyaam Satija, Martin G Walsh, Aaron Gou, Ammu V Alvarez, Matthew C Henn, Asvin M Ganapathi, Kukbin Choi, Bryan A Whitson","doi":"10.1097/TP.0000000000005803","DOIUrl":"10.1097/TP.0000000000005803","url":null,"abstract":"<p><strong>Background: </strong>Donation after circulatory death (DCD) is increasingly utilized to expand the donor pool. Within DCD, direct procurement and perfusion (DPP) and thoracoabdominal normothermic regional perfusion (TA-NRP) have emerged as distinct procurement strategies. Yet, outcomes remain unclear especially in combination with ex vivo lung perfusion (EVLP).</p><p><strong>Methods: </strong>The United Network for Organ Sharing database was queried for adult lung transplants performed between December 2019 and March 2025. Recipients were stratified as donation after brain death (DBD), DCD DPP, or DCD TA-NRP. Propensity score matching was performed for DBD versus DCD, DBD versus DPP, DBD versus TA-NRP, and DPP versus TA-NRP comparisons. Additional analyses included DBD versus DCD EVLP subgroups. Outcomes included perioperative morbidity, primary graft dysfunction grade 3 (PGD3), and survival.</p><p><strong>Results: </strong>DCD recipients demonstrated increased perioperative morbidity including longer hospitalization (22 versus 19 d, P < 0.001), greater postoperative ECMO use (15.2% versus 8.1%, P < 0.001), and higher PGD3 incidence (25.6% versus 15.6%, P < 0.001) compared with DBD, though survival was similar ( P = 0.74). TA-NRP and DPP lungs had comparable outcomes, with TA-NRP showing slightly lower perioperative morbidity. Among EVLP recipients, DCD EVLP lungs were associated with longer hospitalization (26 versus 20 d, P < 0.001), higher ECMO use (19.2% versus 10.1%, P = 0.004), and a trend toward lower survival, though not statistically significant.</p><p><strong>Conclusions: </strong>DCD lungs yield survival comparable to DBD despite greater perioperative morbidity. NRP procurement may mitigate morbidity relative to DPP. Incorporating NRP into DCD practice may enhance lung utilization while maintaining acceptable outcomes.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2122-e2134"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148266358","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Liver-Kidney Transplantation in the Safety Net Era: Less Is More? 安全网时代的同步肝肾移植:少即是多?
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-07-28 DOI: 10.1097/TP.0000000000005866
Nicholas Kosinski, Arun B Jesudian, Danielle Brandman
{"title":"Simultaneous Liver-Kidney Transplantation in the Safety Net Era: Less Is More?","authors":"Nicholas Kosinski, Arun B Jesudian, Danielle Brandman","doi":"10.1097/TP.0000000000005866","DOIUrl":"10.1097/TP.0000000000005866","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e1994-e1995"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148607895","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the Letter to the Editor: "The Role of mTOR Inhibitors in CMV Prevention: An Overlooked Aspect of the Fourth International CMV Consensus Guidelines". 对致编辑的信的回复:“mTOR抑制剂在CMV预防中的作用:第四次国际CMV共识指南的一个被忽视的方面”。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-08-11 DOI: 10.1097/TP.0000000000005874
Camille N Kotton, Atul Humar
{"title":"Response to the Letter to the Editor: \"The Role of mTOR Inhibitors in CMV Prevention: An Overlooked Aspect of the Fourth International CMV Consensus Guidelines\".","authors":"Camille N Kotton, Atul Humar","doi":"10.1097/TP.0000000000005874","DOIUrl":"10.1097/TP.0000000000005874","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2146-e2147"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148713698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers. 供肝1周常温机器灌注平台的建立
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 DOI: 10.1097/TP.0000000000005915
Julia Hofmann, Christina Bogensperger, Andras T Meszaros, Madita L Buch, Florian Nardin, Benno Cardini, Bettina Zelger, Martin Hermann, Margot Fodor, Franka Messner, Fabian Scherbauer, Magdalena Bordt, Felix J Krendl, Hannah Esser, Silvia Oberparleiter, Valeria Berchtold, Marlene Pühringer, Simon Mathis, Gabriel Putzer, Andrea Griesmacher, Christian Irsara, Harald Schennach, Judith Martini, Stefan Scheidl, Christian Margreiter, Manuel Maglione, Annemarie Weissenbacher, Rupert Oberhuber, Dietmar Öfner, Jakob Troppmair, Thomas Resch, Theresa Hautz, Stefan Schneeberger
{"title":"Establishing a Platform for 1-Wk Normothermic Machine Perfusion of Donor Livers.","authors":"Julia Hofmann, Christina Bogensperger, Andras T Meszaros, Madita L Buch, Florian Nardin, Benno Cardini, Bettina Zelger, Martin Hermann, Margot Fodor, Franka Messner, Fabian Scherbauer, Magdalena Bordt, Felix J Krendl, Hannah Esser, Silvia Oberparleiter, Valeria Berchtold, Marlene Pühringer, Simon Mathis, Gabriel Putzer, Andrea Griesmacher, Christian Irsara, Harald Schennach, Judith Martini, Stefan Scheidl, Christian Margreiter, Manuel Maglione, Annemarie Weissenbacher, Rupert Oberhuber, Dietmar Öfner, Jakob Troppmair, Thomas Resch, Theresa Hautz, Stefan Schneeberger","doi":"10.1097/TP.0000000000005915","DOIUrl":"https://doi.org/10.1097/TP.0000000000005915","url":null,"abstract":"<p><strong>Background: </strong>Although short-term (24 h) normothermic machine perfusion (NMP) is suitable to assess liver quality before transplantation, prolonged NMP offers the potential for modification, regeneration, and repair of marginal organs. We systematically aimed for the development of a reproducible perfusion protocol for long-term ex situ liver preservation (LTP), using a commercially available perfusion device without hardware modification.</p><p><strong>Methods: </strong>Livers retrieved from domestic pigs (N = 18) were perfused for up to 7 d (OrganOx Metra). A precision-cut liver slice culture model was applied to assess and determine the perfusate recipe. The perfusion protocol was assessed and validated in a stepwise process and later evaluated in nontransplanted human livers (N = 22).</p><p><strong>Results: </strong>The stepwise development using porcine livers finally resulted in 7-d perfusion with stable function and preserved morphology. Key advancements include red blood cell substitution, bile excretion modifications, and expanded antiinfective therapy. Applying the perfusion protocol in nontransplantable human donor livers enabled 7-d NMP in 4 livers, while control livers deteriorated after 66 [48-84] h NMP. Preserved bile production, low-levels of free hemoglobin and a low-degree of inflammation were identified as key factors for successful LTP.</p><p><strong>Conclusions: </strong>Seven-day preservation of porcine and human livers using the LTP protocol in an unmodified, commercial perfusion system is feasible; thus, the model system is suitable for treating and recovering livers, which may help to limit global organ shortage.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":""},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149115289","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expanding Access to Liver Transplantation Through Cost-effective Normothermic Machine Liver Perfusion: An Organ Procurement Organization-based Model and its Clinical Impact. 通过具有成本效益的恒温机器肝灌注扩大肝移植的可及性:基于器官采购组织的模式及其临床影响。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-06-17 DOI: 10.1097/TP.0000000000005786
Ronald A Squires, Ashley N Milam, Josiah D Wagler, Vivek Kohli, Ananth Srinivasan, Jeffrey P Orlowski
{"title":"Expanding Access to Liver Transplantation Through Cost-effective Normothermic Machine Liver Perfusion: An Organ Procurement Organization-based Model and its Clinical Impact.","authors":"Ronald A Squires, Ashley N Milam, Josiah D Wagler, Vivek Kohli, Ananth Srinivasan, Jeffrey P Orlowski","doi":"10.1097/TP.0000000000005786","DOIUrl":"10.1097/TP.0000000000005786","url":null,"abstract":"<p><strong>Background: </strong>The shortage of transplantable livers, especially from donation after circulatory death (DCD) donors, remains a major challenge. Normothermic machine liver perfusion (NMLP) can further evaluate and potentially rehabilitate marginal grafts, but high costs and logistical barriers restrict its adoption.</p><p><strong>Methods: </strong>A nonprofit organ procurement organization (OPO) integrated NMLP into its infrastructure, creating a cost-effective, equitable model for liver graft evaluation. This article describes the OPO-based approach and reports transplant outcomes from 1 regional partner center between May 2022 and July 2025.</p><p><strong>Results: </strong>OPO adoption of NMLP enabled efficient deployment, reduced graft turndowns, and expanded donor acceptance criteria. In 2024 alone, the OPO perfused 75 livers, of which 61 were DCD donors, and 60 were successfully transplanted. At 1 partner institution, 72 NMLP-supported transplants were performed (86.1% DCD), with excellent 1-y survival (94.6%). Severe ischemic cholangiopathy was rare (1.6%), and most biliary complications were managed endoscopically. High-acuity recipients-including Model for End-stage Liver Disease score of 40, dual-organ, and retransplant candidates-benefited.</p><p><strong>Conclusions: </strong>An OPO-based NMLP model is scalable, sustainable, and equitable. It increases utilization of DCD livers, expands donor and recipient criteria, and improves regional access to transplantation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2082-e2086"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148266330","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation. 从基因编辑到外生:猪作为移植免疫兼容器官的来源。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-08-04 DOI: 10.1097/TP.0000000000005845
Asghar Ali, Mayuko Kurome, Daniel Reichart, Bruno Reichart, Mary G Garry, Hideki Masaki, Hiromitsu Nakauchi, David H Sachs, Daniel J Garry, Eckhard Wolf
{"title":"From Gene Editing to Exogenesis: Pigs as a Source of Immune-compatible Organs for Transplantation.","authors":"Asghar Ali, Mayuko Kurome, Daniel Reichart, Bruno Reichart, Mary G Garry, Hideki Masaki, Hiromitsu Nakauchi, David H Sachs, Daniel J Garry, Eckhard Wolf","doi":"10.1097/TP.0000000000005845","DOIUrl":"10.1097/TP.0000000000005845","url":null,"abstract":"<p><p>The persistent shortage of human organs for transplantation has intensified efforts to develop alternative sources, specifically xenotransplantation and exogenesis. Xenotransplantation uses genetically engineered pigs to provide organs, tissues, and cells for clinical use. Significant progress has occurred in developing multigene-modified pigs that lack glycan xenoantigens while expressing human complement and coagulation regulators. These modifications have successfully mitigated hyperacute, antibody-mediated, and cellular rejection in preclinical nonhuman primate models. Recent compassionate-use cases in humans have demonstrated the feasibility of heart, kidney, and liver xenotransplantation, although achieving long-term survival remains a challenge. Complementing this approach, exogenesis aims to generate human-compatible organs within animal hosts through interspecies chimerism. Although advances in establishing organ niches and overcoming xeno-barriers have yielded preliminary success in heart, pancreas, and muscle development, formidable immune and developmental hurdles remain. Together, these approaches offer promising strategies to expand the donor organ pool and address the growing global demand for transplantation. Further advances in genetic engineering, immune modulation, and developmental biology, supported by rigorous preclinical and clinical evaluation, will be critical for widespread translation. This review outlines the current progress, major challenges, and future directions in xenogeneic and exogenic organ generation.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e1996-e2006"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148670560","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Cellular Bridge Between Transient Chimerism and Transplant Tolerance. 瞬时嵌合与移植耐受之间的新型细胞桥梁。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-07-20 DOI: 10.1097/TP.0000000000005853
Thiago J Borges
{"title":"A Novel Cellular Bridge Between Transient Chimerism and Transplant Tolerance.","authors":"Thiago J Borges","doi":"10.1097/TP.0000000000005853","DOIUrl":"10.1097/TP.0000000000005853","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e1983-e1985"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148536949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Highlights in Liver Transplantation From the 2025 World Transplant Congress. 来自2025年世界移植大会的肝移植亮点。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-05-18 DOI: 10.1097/TP.0000000000005769
Dempsey L Hughes, Yanik J Bababekov
{"title":"Highlights in Liver Transplantation From the 2025 World Transplant Congress.","authors":"Dempsey L Hughes, Yanik J Bababekov","doi":"10.1097/TP.0000000000005769","DOIUrl":"10.1097/TP.0000000000005769","url":null,"abstract":"","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e1972-e1974"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147975709","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meta-analysis of Short-term Clinical and Survival Outcomes of Full-left-full-right Split Liver Transplantation for 2 Recipients. 2例全左全右分离肝移植短期临床和生存结果荟萃分析。
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-06-29 DOI: 10.1097/TP.0000000000005833
Shahin Hajibandeh, Shahab Hajibandeh, Farhan Ahmad, Debashis Haldar, Rebeca Sanabria-Mateos, Nikolaos Chatzizacharias, Bobby V M Dasari, David C Bartlett, Keith J Roberts
{"title":"Meta-analysis of Short-term Clinical and Survival Outcomes of Full-left-full-right Split Liver Transplantation for 2 Recipients.","authors":"Shahin Hajibandeh, Shahab Hajibandeh, Farhan Ahmad, Debashis Haldar, Rebeca Sanabria-Mateos, Nikolaos Chatzizacharias, Bobby V M Dasari, David C Bartlett, Keith J Roberts","doi":"10.1097/TP.0000000000005833","DOIUrl":"10.1097/TP.0000000000005833","url":null,"abstract":"<p><p>This study aimed to evaluate outcomes of full-left-full-right split liver transplantation (FLFR-SLT) for 2 recipients. Comparative outcomes of full-right versus full-left grafts, and FLFR-SLT versus whole liver transplantation (WLT) were evaluated. A systematic search of electronic data sources and bibliographic reference lists were conducted. All studies reporting comparative outcomes of FLFR-SLT were included and their risk of bias were assessed. Estimate of effect size for hepatic artery thrombosis (HAT), venous complications, biliary complications, primary nonfunction (PNF), small-for-size syndrome, retransplantation, and graft and patient survival were determined using random-effects model. Sixteen observational studies reporting a total of 3139 patients were included. Full-right (n = 220) and full-left (n = 230) SLT were associated with no significant difference in HAT (OR 1.09; P = 0.88), venous complications (RD -0.02; P = 0.51), biliary complications (OR 1.04; P = 0.89), small-for-size (RD -0.02; P = 0.34), PNF (OR 0.51; P = 0.26), or retransplantation (OR 0.46; P = 0.19). Moreover, there was no significant difference in 1-y (OR 0.99; P = 0.99), 5-y (OR 0.90; P = 0.73) patient-survival, or 1-y (OR 1.13; P = 0.72), and 5-y (OR 1.10; P = 0.75) graft-survival between 2 groups. Although FLFR-SLT was associated with similar risk of HAT (OR 2.68; P = 0.15) when compared with WLT (n = 2689), it significantly increased risk of venous complications (OR 32.8; P = 0.002) and biliary complications (OR 3.41; P = 0.0001) and decreased 1-y (OR 0.33, P < 0.00001) and 5-y (OR 0.52, P = 0.01) graft-survival and 1-y patient survival (OR 0.46, P = 0.0003). The meta-analysis of best available evidence (level 2a) indicates that full-right and full-left split liver transplantation have comparable short-term clinical, graft-and patient-survival outcomes. However, when compared with WLT, FLFR-SLT significantly increases posttransplantation complications and decreases graft and patient survival.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2017-e2029"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148346254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy. 根据移植前eGFR分类的同步肝肾与肝移植:2017年OPTN政策的影响
IF 4.9 2区 医学
Transplantation Pub Date : 2026-10-01 Epub Date: 2026-06-30 DOI: 10.1097/TP.0000000000005776
Yitian Fang, Sarah Bouari, Jacqueline van de Wetering, Caroline M den Hoed, Ron W F de Bruin, Robert J Porte, Wojciech G Polak, Robert C Minnee
{"title":"Simultaneous Liver-kidney Versus Liver Transplantation Categorized by Pretransplant eGFR: Impact of the 2017 OPTN Policy.","authors":"Yitian Fang, Sarah Bouari, Jacqueline van de Wetering, Caroline M den Hoed, Ron W F de Bruin, Robert J Porte, Wojciech G Polak, Robert C Minnee","doi":"10.1097/TP.0000000000005776","DOIUrl":"10.1097/TP.0000000000005776","url":null,"abstract":"<p><strong>Background: </strong>Simultaneous liver-kidney transplantation (SLKT) has increased substantially in the United States since adoption of the Model for End-stage Liver Disease-based allocation, now comprising 9%-10% of liver transplants. The survival benefit of SLKT compared with liver transplantation alone (LTA) remains uncertain.</p><p><strong>Methods: </strong>Using the Organ Procurement and Transplant Network (OPTN)/United Network for Organ Sharing registry, we analyzed 63 407 adult liver transplants (57 780 LTA; 5627 SLKT) performed between 2010 and 2019. Patient survival was evaluated across pretransplant estimated glomerular filtration rate (eGFR) categories and according to transplant era before and after implementation of the 2017 OPTN policy.</p><p><strong>Results: </strong>Among patients with pretransplant eGFR ≥30 mL/min/1.73 m 2 , SLKT conferred no survival benefits, and LTA recipients achieved comparable or better long-term outcomes. In contrast, SLKT significantly reduced mortality in patients with advanced renal dysfunction. For eGFR 15-29 mL/min/1.73 m 2 , SLKT reduced 1-, 3-, and 5-y mortality by 25%, 15%, and 13%, respectively. For eGFR <15 mL/min/1.73 m 2 , SLKT reduced 1-, 3-, 5-, and 10-y mortality by 32%, 24%, 22%, and 17%, respectively. Following implementation of the 2017 OPTN policy and \"Safety Net\" policies, SLKT procedures declined. The survival advantage of SLKT observed in the pre-policy era was no longer evident post-policy, with 1.4% of LTA recipients undergoing kidney after liver transplantation under \"Safety Net\" allocation priority.</p><p><strong>Conclusions: </strong>SLKT is associated with survival benefit in patients with severe renal dysfunction (eGFR <30 mL/min/1.73 m 2 ). Following implementation of the 2017 OPTN policy, this survival difference was no longer evident, and SLKT procedures were reduced without compromising survival. These findings support a stage-specific allocation strategy incorporating the \"Safety Net\" framework.</p>","PeriodicalId":23316,"journal":{"name":"Transplantation","volume":" ","pages":"e2096-e2104"},"PeriodicalIF":4.9,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13585157/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148369805","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书